Frontlight ResearchEarly access
What researchers published on Liver cirrhosis
40,153 papers, newest first.
Showing 40 of 40,153
ReviewThe potential benefit of sodium glucose cotransporter (SGLT)-2 inhibitors in liver cirrhosis: A mini review.Therapeutic advances in gastroenterology
ReviewBiomarkers to assess early signs of fibro-inflammatory disease modification following short-term therapeutic intervention in people living with MASLD/MASH: A systematic scoping review.PloS one
The Clinical Value of D-D, AT-Ⅲ, NLR, PLT and ALB Measurement in Liver Diseases.Clinical laboratory
Predicting Cirrhotic Patients' Transition From Compensated to Decompensated Stage: A Graph-Based Multitask Deep Learning Method.JMIR medical informatics
Reply to Letter to the Editor on Beyond Prophylaxis: Antimicrobial Stewardship for Bacterial Infections in Cirrhosis.United European gastroenterology journal
Genes That Reliably Differentiate Liver-Fibrosis Stages Identified Using a Novel Integrated Statistical and Machine-Learning Algorithm.Genetic epidemiology
Regulatory T-Cell Dynamics During and After Direct Acting Antivirals in Cirrhotic HCV Genotype 4 Patients.Journal of viral hepatitis
Development and internal validation of VA-BLED for 1-year esophageal variceal bleeding risk in cirrhosis.PloS one
ReviewHepatic metabolic plasticity: From physiological adaptation to energy overload-associated pathological progression and therapeutic targeting.Journal of physiology and biochemistry
Integrative transcriptomic and single-nucleus analyses identify microbiota-metabolite-associated immune signatures of fibrosis severity in MASLD.PloS one
Two-dimensional speckle-tracking imaging for assessing cardiac dysfunction in liver cirrhosis: correlation with Child-Pugh score.Cardiovascular ultrasound
Review[Screening, diagnosis, treatment, and follow-up of hepatitis C virus-related liver disease].Orvosi hetilap
Inflammatory bowel disease increases the risk of liver cirrhosis: a retrospective population-based study.Sage open chronic disease
PRPF19 drives hepatic stellate cell activation and liver fibrosis via PKM2-mediated glycolytic reprogramming.Nature communications
Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Anthropometric measurements, nutritional status, and diet quality of cirrhosis patients: Comparison of two etiologies.Hepatology forum
Associations of Myosteatosis with Osteoporosis, Vertebral Fractures, and Long-Term Prognosis in Patients with Cirrhosis.Journal of clinical medicine
Transcriptome Analysis Reveals the Role of Partial Lymphatic Vessel Ligation in Rats with Cirrhotic Portal Hypertension.Cells
Interassay and interlaboratory comparison of von Willebrand factor antigen as a diagnostic and prognostic biomarker in advanced chronic liver disease.Research and practice in thrombosis and haemostasis
Metabolomic Differences Between Wild and Cultivated Ophiocordyceps sinensis Identify Source-Associated Metabolites with Predicted Antifibrotic Relevance.International journal of molecular sciences
Meta-analysisSilymarin-Based Therapies in Chronic Liver Disease: A Systematic Review of Biochemical, Cardiometabolic, Steatosis, and Fibrosis-Related Outcomes.Nutrients
ReviewIntercepting hepatocellular carcinoma in chronic hepatitis B: a structured critical review of Chinese herbal medicine and the immune-fibrotic evidence.Frontiers in immunology
Effects of Ketanserin, Reserpine, VEGF, and HGF as Monotherapy and Combination Therapy in Experimental Liver Cirrhosis.Bulletin of experimental biology and medicine
Therapeutic Targeting of Hepatic Stellate Cell Inactivation and Collagen Degradation by IC-2 Mitigates Liver Fibrosis.International journal of molecular sciences
Effectiveness and Safety of Thalidomide for Gastric Antral Vascular Ectasia-Related Recurrent Gastrointestinal Bleed in Liver Cirrhosis: Prospective Observational Study.Journal of clinical and experimental hepatology
Tubastatin A Mitigates Lipotoxicity, Inflammation and Fibrosis Through Downregulation of HDAC6 and Modulation of AMPK-FGF21 Axis in Metabolic Dysfunction-Associated Steatohepatitis.Inflammation
Percutaneous cholecystostomy for acute cholecystitis in patients with cirrhosis is associated with healthcare burden and mortality.Medicine
Case reportNoncirrhotic Portal Hypertension and Diagnostic Pitfalls in Severe Polycystic Liver Disease: A Case Report.Cureus
Impact of Self-Reported Race and Ethnicity in Hospitalized Patients With Acute Kidney Injury and Cirrhosis: Results from the HRS-HARMONY Consortium.Kidney medicine
Integrative multi-omic profiling reveals a spatially organized GPNMB⁺ monocyte-derived macrophage-NAMPT axis driving Th17 activation and fibrotic remodeling in cholestatic liver disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Impact of Guideline-Based Acute Kidney Injury Care Processes on Outcomes in Hospitalized Patients With Decompensated Cirrhosis.Journal of clinical gastroenterology
Dysregulated apoptosis in the spleen from patients with splenomegaly due to cirrhosis.Folia histochemica et cytobiologica
MAIT cells exacerbate early liver fibrosis by downsizing the intrahepatic regulatory T cell compartment.Science advances
Sivelestat attenuates thrombus burden and NET-associated thrombo-inflammatory responses in experimental non-cirrhotic portal vein thrombosis.Thrombosis research
Real world data to improve hepatocellular carcinoma surveillance in cirrhosis.Revista espanola de enfermedades digestivas
Validating sarcopenia definitions in Asian patients with cirrhosis: a first and necessary step to characterizing muscle health.Hepatology international
Design, Synthesis, and Antifibrotic Evaluation of Silicon-Incorporated Alkyl Hydrazide Analogs of Tubastatin A: HDAC3 Selective Inhibitor for Ameliorating Liver Fibrosis.Journal of medicinal chemistry
Magnetic particle imaging reveals microenvironment-driven retention of SPIO-labeled MSCs and enables CXCR3 engineering to enhance antifibrotic therapy.Journal of nanobiotechnology
Case reportPleural empyema and perisplenic abscess caused by Clostridioides difficile in a patient with liver cirrhosis and previous C. difficile colitis: a case report.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Efficacy and safety of dabigatran in cirrhosis with chronic portal vein thrombosis: A randomized, placebo-controlled double-blind trial (DAB-PVT).The American journal of gastroenterology